Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.
about
Single-dose safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, in HIV-infected children.Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 yearsPharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors.Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1.Stability of extemporaneously prepared saquinavir formulations.
P2860
Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Combination therapy with saqui ...... unodeficiency virus infection.
@en
Combination therapy with saqui ...... unodeficiency virus infection.
@nl
type
label
Combination therapy with saqui ...... unodeficiency virus infection.
@en
Combination therapy with saqui ...... unodeficiency virus infection.
@nl
prefLabel
Combination therapy with saqui ...... unodeficiency virus infection.
@en
Combination therapy with saqui ...... unodeficiency virus infection.
@nl
P2093
P1476
Combination therapy with saqui ...... munodeficiency virus infection
@en
P2093
C V Fletcher
H Schwarzwald
N R Calles
P304
P356
10.1097/00006454-200107000-00006
P577
2001-07-01T00:00:00Z